Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5628000 | Epilepsy & Behavior | 2017 | 6 Pages |
Abstract
VNS for drug-resistant epilepsy is associated with improvement on various QOL metrics subjectively rated by physicians. QOL improvement is associated with favorable seizure outcome and a higher likelihood of generator replacement, suggesting satisfaction with therapy. It is important to consider QOL metrics in neuromodulation for epilepsy, given the deleterious effects of seizures on patient QOL.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Dario J. Englot, Kevin H. Hassnain, John D. Rolston, Stephen C. Harward, Saurabh R. Sinha, Michael M. Haglund,